Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosine

Advances in Enzyme Regulation

Volumn 37, Issue , 1997, Pages 3-16

  Cory, Joseph G ^a   Nelson, Tonie O ^a   Somerville, Lilla ^a   Cory, Ann H ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORODEOXYADENOSINE; CYTARABINE; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE; DEOXYRIBONUCLEOSIDE KINASES; PHOSPHOTRANSFERASE;

ANIMAL; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CULTURE; CELL DIVISION; CONFERENCE PAPER; DRUG EFFECT; DRUG RESISTANCE; ENZYME ANALYSIS; ENZYME ASSAY; ENZYMOLOGY; KINETICS; LEUKEMIA L 1210; METABOLISM; MOUSE; NONHUMAN; PATHOLOGY;

ANIMALS; CELL DIVISION; CLADRIBINE; CYTARABINE; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE; DRUG RESISTANCE, NEOPLASM; KINETICS; LEUKEMIA L1210; MICE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030820323     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(96)00006-4     Document Type: Conference Paper

References (17)

1. 1. T. A. KRENITSKY, J. V. TUTTLE, G. W. KOSZALKA, I. S. CHEN, L. M. BEACHAM III, J. L. RIDEOUT and G. B. ELION, Deoxycytidine kinase from calf thymus substrate and inhibitor specificity, J. Biol. Chem. 257, 4053-4061 (1976).
2. 2. R. L. MOMPARLER and G. A. FISCHER, Mammalian deoxynucleoside kinases. I. Deoxycytidine kinase: purification, properties, and kinetic studies with cytosine arabinoside, J. Biol. Chem. 243, 4298-4304 (1968).
3. 3. C. BOHMAN and S. ERIKSSON, Deoxycytidine kinase from human leukemia spleen: purification and characterization of the homogeneous enzyme, Biochemistry 27, 4258-4265 (1988).
4. 4. A. HABTEYESUS, A. NORDENSKJOLD, C. BOHMAN and S. ERIKSSON, Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity, Biochem. Pharmacol. 42, 1829-1836 (1991).
5. 5. D. Y. BOUFFARD, J. LALIBERTE and R. L. MOMPARLER, Kinetic studies on 2′,2′-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase, Biochem. Pharmacol. 45, 1857-1861 (1993).
6. 6. J. K. OWENS, D. S. SHEWACH, B. ULLMAN and B. S. MITCHELL, Resistance to 1-β-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene, Cancer Res. 52, 2389-2393 (1992).
7. 7. L.-S. LEE and Y.-C. CHENG, Human deoxythymidine kinase. I. Purification and general properties of the mitochondrial isoenzymes derived from blast cells of acute myelocytic leukemia, J. Biol. Chem. 251, 2600-2604 (1976).
8. 8. K. BHALLA, R. NAYAK and S. GRANT, Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-β-D-arabinofuranosylcytosine, Cancer Res. 44, 5029-5036 (1984).
9. 9. D. S. SHEWACH, P. E. DADDONA, E. ASHCRAFT and B. S. MITCHELL, Metabolism and selective cytotoxicity of 9-β-D-arabinofuranosylguanine in human lymphoblasts, Cancer Res. 45, 1008-1014 (1985).
10. 10. V. VERHOEF, J. SARUP and A. FRIDLAND, Identification of the mechanism of activation of 9-β-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases, Cancer Res. 41, 4478-4483 (1981).
11. 11. R. A. LEWIS and L. LINK, Phosphorylation of arabinosylguanine by a mitochondrial enzyme of bovine liver, Biochem. Pharmacol. 38, 2001-2006 (1989).
12. 12. A. H. CORY, T. C. OWEN, J. A. BARLTROP and J. G. CORY, Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture, Cancer Commun. 3, 207-212 (1991).
13. 13. O. H. LOWRY, N. J. ROSEBROUGH, A. L. FARR and R. J. RANDALL, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265-275 (1951).
14. 14. G. WEBER, H. N. JAYARAM, K. PILLWEIN, Y. NATSUMEDA, M. REARDON and Y. S. ZHEN, Salvage pathways as targets of chemotherapy, Advan. Enzyme Regul. 26, 335-352 (1987).
15. 15. E. G. CHOTTINER, D. S. SHEWACH, N. S. DATTA, E. ASHCRAFT, D. GRIBBEN, D. GINSBURG, I. H. FOX and B. S. MITCHELL, Cloning and expression of human deoxycytidine kinase cDNA, Proc. Natl Acad. Sci. 88, 1531-1535 (1991).
16. 16. L. WANG, A. KARLSSON, E. S. J. ARNER and S. ERIKSSON, Substrate specificity of mitochondrial 2′-deoxyguanosine kinase: Efficient phosphorylation of 2-Chlorodeoxyadenosine (CdA), J. Biol. Chem. 268, 22847-22852 (1993).
17. 17. E. S. J. ARNER, T. SPASOKOUKOTSKAJA and S. ERIKSSON, Selective assays for thymidine kinase 1 and 2 deoxycytidine kinase and their activities in extracts from human cells and tissues, Biochem. Biophys. Res. Commun. 188, 712-718 (1992).